Dec 12, 2023 / 03:30PM GMT
Bob Yedid LifeSci Advisors-Managing Director
Okay. I think we're going to get started. My name is Bob Yedid. I'm a Managing Director at LifeSci Advisors. Happy to be working with Ligand. We're delighted that all of you are here today, both in person as well as on the webcast. We planned the full agenda for you and the CEO, Todd Davis, sitting right here, is going to be basically starting off today. If you could save your questions to the end, there will be a Q&A session. And for those who are basically on the webcast, you'll be able to submit your questions in the basic question box on the online call manager.
Before we begin, there will be slides that we're using to guide our discussions. Today, we'll be using non-GAAP financial measures and some of the statements will be forward looking. We'll have a Q&A session to conclude our formal remarks, as I mentioned. Additional information regarding the risks and other matters concerning Ligand could be found in Ligand's summary press release that will be issued later today, along with slides associated with this call, and our periodic
Ligand Pharmaceuticals Inc To Host Investor Day Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers